EUCTR2010-020127-52-GB. A Phase 2a, double blind, placebo controlled study to evaluate the efficacy of MEDI-563 in subjects with moderate to severe COPD and sputum eosinophilia

Authors
Category Primary study
Registry of Trials2010-020127-52
Year 2010
This article has no abstract
Epistemonikos ID: 611a4a2a7a6c11007a19893580a6fcf786bb658b
First added on: May 23, 2023